• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“动脉粥样硬化性滋养物”对 SARS-CoV-2 感染住院死亡率的影响。 钙评分能否识别高危患者?

Impact of the "atherosclerotic pabulum" on in-hospital mortality for SARS-CoV-2 infection. Is calcium score able to identify at-risk patients?

机构信息

Department of Cardiac, Vascular, Thoracic Sciences and Public Health, University of Padua, Padua, Italy.

Department of Medicine, Institute of Radiology, University of Padua, Padua, Italy.

出版信息

Clin Cardiol. 2022 Jun;45(6):629-640. doi: 10.1002/clc.23809. Epub 2022 Mar 30.

DOI:10.1002/clc.23809
PMID:35355295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9110910/
Abstract

BACKGROUND

Although the primary cause of death in COVID-19 infection is respiratory failure, there is evidence that cardiac manifestations may contribute to overall mortality and can even be the primary cause of death. More importantly, it is recognized that COVID-19 is associated with a high incidence of thrombotic complications.

HYPOTHESIS

Evaluate if the coronary artery calcium (CAC) score was useful to predict in-hospital (in-H) mortality in patients with COVID-19. Secondary end-points were needed for mechanical ventilation and intensive care unit admission.

METHODS

Two-hundred eighty-four patients (63, 25 years, 67% male) with proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who had a noncontrast chest computed tomography were analyzed for CAC score. Clinical and radiological data were retrieved.

RESULTS

Patients with CAC had a higher inflammatory burden at admission (d-dimer, p = .002; C-reactive protein, p = .002; procalcitonin, p = .016) and a higher high-sensitive cardiac troponin I (HScTnI, p = <.001) at admission and at peak. While there was no association with presence of lung consolidation and ground-glass opacities, patients with CAC had higher incidence of bilateral infiltration (p = .043) and higher in-H mortality (p = .048). On the other side, peak HScTnI >200 ng/dl was a better determinant of all outcomes in both univariate (p = <.001) and multivariate analysis (p = <.001).

CONCLUSION

The main finding of our research is that CAC was positively related to in-H mortality, but it did not completely identify all the population at risk of events in the setting of COVID-19 patients. This raises the possibility that other factors, including the presence of soft, unstable plaques, may have a role in adverse outcomes in SARS-CoV-2 infection.

摘要

背景

虽然 COVID-19 感染的主要死亡原因是呼吸衰竭,但有证据表明心脏表现可能导致总体死亡率,甚至可能是死亡的主要原因。更重要的是,人们认识到 COVID-19 与血栓并发症的高发率有关。

假说

评估冠状动脉钙 (CAC) 评分是否可用于预测 COVID-19 患者的住院死亡率。次要终点为需要机械通气和入住重症监护病房。

方法

分析了 284 例经证实患有严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染的患者的非对比胸部 CT 以计算 CAC 评分。检索了临床和影像学数据。

结果

CAC 患者入院时炎症负担更高(D-二聚体,p=0.002;C 反应蛋白,p=0.002;降钙素原,p=0.016),入院和峰值时高敏心肌肌钙蛋白 I (HScTnI) 更高(p<0.001)。虽然与肺实变和磨玻璃混浊的存在无关,但 CAC 患者双侧浸润的发生率更高(p=0.043),住院死亡率更高(p=0.048)。另一方面,在单变量(p<0.001)和多变量分析(p<0.001)中,峰值 HScTnI>200ng/dl 是所有结果的更好预测指标。

结论

我们研究的主要发现是 CAC 与住院死亡率呈正相关,但它并未完全确定 COVID-19 患者发生事件的所有高危人群。这表明其他因素,包括不稳定的软斑块的存在,可能在 SARS-CoV-2 感染的不良结果中起作用。

相似文献

1
Impact of the "atherosclerotic pabulum" on in-hospital mortality for SARS-CoV-2 infection. Is calcium score able to identify at-risk patients?“动脉粥样硬化性滋养物”对 SARS-CoV-2 感染住院死亡率的影响。 钙评分能否识别高危患者?
Clin Cardiol. 2022 Jun;45(6):629-640. doi: 10.1002/clc.23809. Epub 2022 Mar 30.
2
Lung Opacity and Coronary Artery Calcium Score: A Combined Tool for Risk Stratification and Outcome Prediction in COVID-19 Patients.肺部混浊与冠状动脉钙化评分:COVID-19患者风险分层和预后预测的联合工具
Acad Radiol. 2022 Jun;29(6):861-870. doi: 10.1016/j.acra.2022.02.019. Epub 2022 Feb 28.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
A Meta-Analysis: Coronary Artery Calcium Score and COVID-19 Prognosis.一项荟萃分析:冠状动脉钙评分与 COVID-19 预后。
Med Sci (Basel). 2022 Jan 21;10(1):5. doi: 10.3390/medsci10010005.
5
New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.纽约市中心医院新冠肺炎的经历与当前数据:美国新冠疫情中心的回顾性分析
J Med Internet Res. 2020 Sep 18;22(9):e20548. doi: 10.2196/20548.
6
Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study.新型冠状病毒病 2019(COVID-19)相关凝血功能障碍及其对中国深圳患者结局的影响:一项回顾性队列研究。
Thromb Res. 2020 Nov;195:62-68. doi: 10.1016/j.thromres.2020.07.015. Epub 2020 Jul 9.
7
Development and validation of COVID-19 Radiological Risk Score (COVID-RRS): a multivariable radiological score to estimate the in-hospital mortality risk in COVID-19 patients.COVID-19 放射学风险评分(COVID-RRS)的制定与验证:一种多变量放射学评分,用于评估 COVID-19 患者住院期间的死亡风险。
Eur Rev Med Pharmacol Sci. 2023 Jan;27(1):384-394. doi: 10.26355/eurrev_202301_30892.
8
Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.在纽约一家医院中对 4404 人进行的 COVID-19 调查队列研究,以及 ICU 护理和通气的预测因素。
Ann Emerg Med. 2020 Oct;76(4):394-404. doi: 10.1016/j.annemergmed.2020.05.011. Epub 2020 May 11.
9
Simple demographic characteristics and laboratory findings on admission may predict in-hospital mortality in patients with SARS-CoV-2 infection: development and validation of the covid-19 score.简单的人口统计学特征和入院时的实验室检查结果可能预测 SARS-CoV-2 感染患者的住院死亡率:covid-19 评分的制定和验证。
BMC Infect Dis. 2021 Sep 14;21(1):945. doi: 10.1186/s12879-021-06645-z.
10
Coronary Artery Calcifications Are Associated With More Severe Multiorgan Failure in Patients With Severe Coronavirus Disease 2019 Infection: Longitudinal Results of the Maastricht Intensive Care COVID Cohort.冠状动脉钙化与严重 2019 冠状病毒病感染患者更严重的多器官衰竭相关:马斯特里赫特重症监护新冠队列的纵向研究结果。
J Thorac Imaging. 2022 Jul 1;37(4):217-224. doi: 10.1097/RTI.0000000000000648. Epub 2022 Apr 13.

引用本文的文献

1
Comparative Prognostic Value of Coronary Calcium Score and Perivascular Fat Attenuation Index in Coronary Artery Disease.冠状动脉疾病中冠状动脉钙化积分与血管周围脂肪衰减指数的比较预后价值
J Clin Med. 2024 Sep 2;13(17):5205. doi: 10.3390/jcm13175205.
2
Coronary artery calcification score as a prognostic indicator for COVID-19 mortality: evidence from a retrospective cohort study in Iran.冠状动脉钙化评分作为COVID-19死亡率的预后指标:来自伊朗一项回顾性队列研究的证据。
Ann Med Surg (Lond). 2024 Apr 4;86(6):3227-3232. doi: 10.1097/MS9.0000000000001661. eCollection 2024 Jun.
3
A Real Pandora's Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19.疫情时代的一个真正的潘多拉魔盒:关于COVID-19所致急性心脏损伤的叙述性综述
Life (Basel). 2022 Jul 20;12(7):1085. doi: 10.3390/life12071085.

本文引用的文献

1
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases.2019冠状病毒病,世纪大流行及其对心血管疾病的影响。
Cardiol Discov. 2021 Nov 22;1(4):233-258. doi: 10.1097/CD9.0000000000000038. eCollection 2021 Dec.
2
Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events.CTA 上的冠状动脉斑块特征可识别心血管事件风险增加的患者。
Curr Opin Cardiol. 2021 Nov 1;36(6):784-792. doi: 10.1097/HCO.0000000000000917.
3
Coronary artery calcification and epicardial adipose tissue as independent predictors of mortality in COVID-19.冠状动脉钙化和心外膜脂肪组织是 COVID-19 患者死亡的独立预测因子。
Int J Cardiovasc Imaging. 2021 Oct;37(10):3093-3100. doi: 10.1007/s10554-021-02276-2. Epub 2021 May 12.
4
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19.新冠肺炎患者冠状动脉钙评估的临床和亚临床冠状动脉疾病的影响。
Atherosclerosis. 2021 Jul;328:136-143. doi: 10.1016/j.atherosclerosis.2021.03.041. Epub 2021 Apr 7.
5
Coronary Calcium Score in COVID-19 Hospitalized Patients.新冠住院患者的冠状动脉钙化评分
JACC Cardiovasc Imaging. 2020 Dec;13(12):2698. doi: 10.1016/j.jcmg.2020.09.038. Epub 2020 Oct 27.
6
Coronary Artery Calcification and Complications in Patients With COVID-19.新型冠状病毒肺炎患者的冠状动脉钙化及并发症
JACC Cardiovasc Imaging. 2020 Nov;13(11):2468-2470. doi: 10.1016/j.jcmg.2020.07.004.
7
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
8
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.肥胖与新冠肺炎确诊患者的死亡率:来自一体化医疗保健组织的研究结果。
Ann Intern Med. 2020 Nov 17;173(10):773-781. doi: 10.7326/M20-3742. Epub 2020 Aug 12.
9
The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis.COVID-19 患者冠状动脉疾病与临床结局的关系:一项单中心回顾性分析。
Coron Artery Dis. 2021 Aug 1;32(5):367-371. doi: 10.1097/MCA.0000000000000934.
10
Subclinical coronary artery disease in COVID-19 patients.新冠病毒肺炎患者的亚临床冠状动脉疾病
Eur Heart J Cardiovasc Imaging. 2020 Sep 1;21(9):1055-1056. doi: 10.1093/ehjci/jeaa202.